Therapeutic Outlook in DLBCL: Evaluating Treatment Sequencing from Front-line to Relapsed Refractory Disease - Episode 3
The Evolving First-line Treatment Approach for DLBCL
An exploration of how first-line treatment practices for DLBCL have evolved with new options, emphasizing the role of relapsed/refractory disease risk in guiding treatment selection.
Video content above is prompted by the following:
- In recent years, how has your practice changed with new 1L treatment options available?
- What role does the potential for relapsed/refractory (RR) disease play in 1L treatment selections?
Related Content:
